These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9037945)

  • 1. Intravenous immunoglobulin as primary therapy or adjuvant therapy to intrauterine fetal blood transfusion: a new approach in the management of severe Rh-immunization.
    Deka D; Buckshee K; Kinra G
    J Obstet Gynaecol Res; 1996 Dec; 22(6):561-7. PubMed ID: 9037945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct fetal intravenous immunoglobulin infusion as an adjunct to intrauterine fetal blood transfusion in rhesus-allommunized pregnancies: a pilot study.
    Deka D; Sharma KA; Dadhwal V; Singh A; Kumar G; Vanamail P
    Fetal Diagn Ther; 2013; 34(3):146-51. PubMed ID: 23941890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic plasma exchange and intravenous immunoglobulin as primary therapy for D alloimmunization in pregnancy precludes the need for intrauterine transfusion.
    Bellone M; Boctor FN
    Transfusion; 2014 Aug; 54(8):2118-21. PubMed ID: 24673470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease.
    Kriplani A; Malhotra Singh B; Mandal K
    Gynecol Obstet Invest; 2007; 63(3):176-80. PubMed ID: 17143009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of red blood cell alloimmunization in pregnancy.
    Ghesquière L; Garabedian C; Coulon C; Verpillat P; Rakza T; Wibaut B; Delsalle A; Subtil D; Vaast P; Debarge V
    J Gynecol Obstet Hum Reprod; 2018 May; 47(5):197-204. PubMed ID: 29476829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report.
    Houston BL; Govia R; Abou-Setta AM; Reid GJ; Hadfield M; Menard C; Noyd J; Main S; Zarychanski R
    Transfus Apher Sci; 2015 Dec; 53(3):399-402. PubMed ID: 26321100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
    Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M
    Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin in the management of severe early onset red blood cell alloimmunisation.
    Vlachodimitropoulou E; Lo TK; Bambao C; Denomme G; Seaward GR; Windrim R; Tessier F; Kelly E; Van Mieghem T; Ryan G
    Br J Haematol; 2023 Jan; 200(1):100-106. PubMed ID: 36100813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease.
    Voto LS; Mathet ER; Zapaterio JL; Orti J; Lede RL; Margulies M
    J Perinat Med; 1997; 25(1):85-8. PubMed ID: 9085208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between obstetric history and Rh(D) alloimmunization severity.
    Lobato G; Soncini CS
    Arch Gynecol Obstet; 2008 Mar; 277(3):245-8. PubMed ID: 17763861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study.
    Maisonneuve E; Dugas A; Friszer S; Toly-Ndour C; Cariot L; Dhombres F; Cortey A; Mailloux A; Carbonne B; Jouannic JM
    J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102119. PubMed ID: 33741541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion.
    Fox C; Martin W; Somerset DA; Thompson PJ; Kilby MD
    Fetal Diagn Ther; 2008; 23(2):159-63. PubMed ID: 18046076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin.
    Palfi M; Hildén JO; Matthiesen L; Selbing A; Berlin G
    Transfus Apher Sci; 2006 Oct; 35(2):131-6. PubMed ID: 17045529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin for the treatment of severe maternal alloimmunization: individual patient data meta-analysis.
    Mustafa HJ; Sambatur EV; Pagani G; D'Antonio F; Maisonneuve E; Maurice P; Zwiers C; Verweij JEJT; Flood A; Shamshirsaz AA; Jouannic JM; Khalil A
    Am J Obstet Gynecol; 2024 Oct; 231(4):417-429.e21. PubMed ID: 38588966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the volume of blood required for the correction of foetal anaemia by intrauterine transfusion during pregnancies of Rh isoimmunised women.
    Santiago MD; Rezende CA; Cabral AC; Leite HV; Osanan GC; Reis ZS
    Blood Transfus; 2010 Oct; 8(4):271-7. PubMed ID: 20967169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmapheresis and intravenous immune globulin for the treatment of D alloimmunization in pregnancy.
    Novak DJ; Tyler LN; Reddy RL; Barsoom MJ
    J Clin Apher; 2008; 23(6):183-5. PubMed ID: 19003884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between maternal antibody type and antenatal course following intrauterine transfusion for red cell alloimmunisation.
    Walsh CA; Russell N; McAuliffe FM; Higgins S; Mahony R; Carroll S; McParland P
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):235-9. PubMed ID: 24075591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic management of fetal anemia: review of standard practice and alternative treatment options.
    Papantoniou N; Sifakis S; Antsaklis A
    J Perinat Med; 2013 Jan; 41(1):71-82. PubMed ID: 23093258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization.
    Ruma MS; Moise KJ; Kim E; Murtha AP; Prutsman WJ; Hassan SS; Lubarsky SL
    Am J Obstet Gynecol; 2007 Feb; 196(2):138.e1-6. PubMed ID: 17306655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal outcomes of intrauterine transfusion for foetal anaemia due to red blood cell alloimmunisation.
    Şavkli AÖ; Çetin BA; Acar Z; Özköse Z; Behram M; Çaypinar SS; Tayyar A; Yüksel MA
    J Obstet Gynaecol; 2020 Jul; 40(5):649-653. PubMed ID: 31462132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.